Skin Substitute Fraud in Arizona: A Wake-Up Call for Wound Care Reimbursement
Summary: In a landmark Medicare fraud case, Arizona’s Alexandra Gehrke and Jeffrey King were sentenced to 15.5 and 14 years in prison, respectively, for billing over $1.2 billion for medically unnecessary amniotic skin substitutes applied to elderly and hospice patients, including those with healed or infected wounds. Operating through Apex Medical and Viking Medical, they ordered oversized grafts (4×6 cm+) for maximum reimbursement, paying kickbacks to untrained sales reps and NPs who ignored medical necessity, leading to $410M forfeiture and $600M+ restitution each. The case exposes systemic vulnerabilities in skin substitute billing for diabetic ulcers and chronic wounds, urging providers to flag red flags like volume-based pay and unverified referrals to protect patients and prevent waste.
Key Highlights:
- Fraud Scheme: Untrained reps targeted vulnerable patients; grafts applied to infection, healed, or non-responsive wounds; kickbacks exceeded $279M.
- Financial Scale: $1.2B false claims to Medicare/TRICARE/CHAMPVA; 50%+ from unnecessary grafts for small ulcers.
- Sentencing: Judge Roslyn Silver called them “criminally greedy”; 29.5 years combined prison, $1.2B restitution.
- Red Flags for Providers: Unwritten billing reassignments, volume-tied pay, small wounds getting large grafts, dual records.
- Implications for Diabetic Ulcers: Highlights reimbursement abuse in wound care; calls for ethical billing, training, and oversight to avoid harming patients with neuropathy or poor perfusion.
Keywords: skin substitute fraud, diabetic ulcers, Medicare reimbursement, kickbacks, wound care ethics